MedPath

Investigation of the effects of vaginal probiotic capsules on prolonging the time of membrane rupture up to delivery and on maternal and fetal complications.

Phase 3
Recruiting
Conditions
prevention of Preterm delivery and maternal and fetal complications.
Preterm labour without delivery
Registration Number
IRCT20141209020264N3
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
64
Inclusion Criteria

live singleton pregnancy
being pregnant for 24 to 32 weeks
no symptoms of chorioamniotic
no sign of fetal distress
no vaginal bleeding
consent of mothers to participate in the study

Exclusion Criteria

sings of chorioamniotic
disturbed fetal health assessment test
vaginal bleeding
unwillingness of patients to continue participating in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prolonging the time of membrane rupture up to 34 weeks. Timepoint: Precise control of mother's vital signs and fetus health, two times of sonography during a week and CBC every other day. Method of measurement: Fetus health is evaluated through NST.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath